BibTex Citation Data :
@article{NMJN18908, author = {Yoshiyuki Kashiwagi}, title = {A Case of Acute Myocardial Infarction during Chemotherapy of Advanced Rectal Cancer}, journal = {Nurse Media Journal of Nursing}, volume = {8}, number = {2}, year = {2018}, keywords = {Acute myocardial infarction; chemotherapy; rectal cancer}, abstract = { Background : Cetuximab, irinotecan, levoforinate, and 5-FU (FOLFIRI) are medicines commonly administered to advanced colorectal cancer patients through chemotherapy. Although this regimen is standardized for recurrent metastatic colorectal cancer, the emerging of myocardial infarction is rare. Purpose : The purpose of this study was to consider the development of myocardial infarction during the chemotherapy of colorectal cancer. Method s : A retrospective case study was conducted to one patient. An 80-year-old man who developed acute myocardial infarction was in chemotherapy with cetuximab + FOLFIRI with multiple lung metastases after rectal cancer surgery. Data were collected from the patient’s medical and nursing records as well as the physiological function test results. Result s : Three days after the 38th administration, the patient visited an emergency outpatient mainly with complaints of dyspnea and back pain. Electrocardiogram showed that the lower wall infarction was suspected. The patient was transferred to a specialized cardiovascular hospital. Emergency coronary angiography was performed in the diagnosis of acute myocardial infarction, and percutaneous coronary intervention was performed. The patient was discharged on the 10 th of disease day. Conclusion : In this case, it was thought that cetuximab + FOLFIRI synergistically induced hyper thrombogenicity, coronary plaque erosion, and acute myocardial infarction. It may also be necessary for interventions such as monitoring the risks in daily living by the medical care providers and guidance on risk avoidance behaviors. }, issn = {2406-8799}, pages = {96--101} doi = {10.14710/nmjn.v8i2.18908}, url = {https://ejournal.undip.ac.id/index.php/medianers/article/view/18908} }
Refworks Citation Data :
Background: Cetuximab, irinotecan, levoforinate, and 5-FU (FOLFIRI) are medicines commonly administered to advanced colorectal cancer patients through chemotherapy. Although this regimen is standardized for recurrent metastatic colorectal cancer, the emerging of myocardial infarction is rare.
Purpose: The purpose of this study was to consider the development of myocardial infarction during the chemotherapy of colorectal cancer.
Methods: A retrospective case study was conducted to one patient. An 80-year-old man who developed acute myocardial infarction was in chemotherapy with cetuximab + FOLFIRI with multiple lung metastases after rectal cancer surgery. Data were collected from the patient’s medical and nursing records as well as the physiological function test results.
Results: Three days after the 38th administration, the patient visited an emergency outpatient mainly with complaints of dyspnea and back pain. Electrocardiogram showed that the lower wall infarction was suspected. The patient was transferred to a specialized cardiovascular hospital. Emergency coronary angiography was performed in the diagnosis of acute myocardial infarction, and percutaneous coronary intervention was performed. The patient was discharged on the 10th of disease day.
Conclusion: In this case, it was thought that cetuximab + FOLFIRI synergistically induced hyper thrombogenicity, coronary plaque erosion, and acute myocardial infarction. It may also be necessary for interventions such as monitoring the risks in daily living by the medical care providers and guidance on risk avoidance behaviors.
Article Metrics:
Last update:
Analysis on the Effect of the Rehabilitation Intervention-Centered Targeted Nursing Model on the Cardiac Function Recovery and Negative Emotions in Patients with Acute Myocardial Infarction
Last update: 2025-05-17 13:43:48
In order for the Department of Nursing, Faculty of Medicine, Universitas Diponegoro to publish and disseminate research articles, we need non-exclusive publishing rights (transferred from the author(s) to the publisher). This is determined by a publishing agreement between the author(s) and the Department of Nursing, Faculty of Medicine, Universitas Diponegoro. This agreement involves the transfer or licensing of the copyright for publishing to the publisher, while authors still retain significant rights to use and share their own published articles. The Department of Nursing, Faculty of Medicine, Universitas Diponegoro supports the need for authors to share, disseminate, and maximize the impact of their research through these rights in any databases.
As the author(s), you have rights to a wide range of uses of your article, including use by your employing institution or company. These author rights can be exercised without the need to obtain specific permission. Authors publishing in the Nurse Media Journal of Nursing have extensive rights to use their works for teaching and scholarly purposes without needing to seek permission, including:
Authors, readers, and third parties can copy and redistribute the material in any medium or format, as well as remix, transform, and build upon the material for any purpose, even commercially, but they must give appropriate credit (including the name of the creator and attribution parties, detailed information about the authors, a copyright notice, an open access license notice, a disclaimer notice, and a link to the material), provide a link to the license, and indicate if changes were made. The publisher will indicate any modification of the material (if any) and retain an indication of previous modifications using a CrossMark Policy and information about Erratum-Corrigendum notifications.
Authors, readers, and third parties can read, print, and download, redistribute or republish the article (e.g., display it in a repository), translate the article, download it for text and data mining purposes, reuse portions or extracts from the article in other works, sell or reuse it for commercial purposes, remix, transform, or build upon the material. They must distribute their contributions under the same license as the original Creative Commons Attribution-ShareAlike (CC BY-SA).
The Authors submitting a manuscript do so on the understanding that if accepted for publication, non-exclusive right for publishing (publishing right) of the article shall be assigned/transferred to Publisher of the Nurse Media Journal of Nursing (Department of Nursing, Faculty of Medicine, Universitas Diponegoro).
Upon acceptance of an article, authors will be asked to complete a 'Copyright Transfer Agreement for Publishing (CTAP)'. An e-mail will be sent to the Corresponding Author confirming receipt of the manuscript together with a 'Copyright Transfer Agreement for Publishing' form by online version of this agreement.
Nurse Media Journal of Nursing and Department of Nursing, Faculty of Medicine, Universitas Diponegoro, the Editors and the Editorial Board make every effort to ensure that no wrong or misleading data, opinions or statements be published in the journal. In any way, the contents of the articles and advertisements published in the Nurse Media Journal of Nursing are sole and exclusive responsibility of their respective authors and advertisers.
Please note that even though we ask for a transfer of copyright for publishing (CTAP), our journal Author(s) retain (or are granted back) significant scholarly rights as mentioned before.
The Copyright Transfer Agreement for Publishing (CTAP) Form can be downloaded here: [Copyright Transfer Agreement for Publishing (CTAP) Form NMJN 2024]
The copyright form should be signed electronically and send to the Editorial Office in the form of original e-mail below:
Dr. Meira Erawati (Editor-in-Chief)Editorial Office of Nurse Media Journal of Nursing Department of Nursing, Faculty of Medicine, Universitas Diponegoro Jl. Prof. Soedarto, Tembalang, Semarang, Central Java, Indonesia 50275Telp.: +62-24-76480919; Fax.: +62-24-76486849E-mail: media_ners@live.undip.ac.id
(This policy statements has been updated at 24th January 2024)
